Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in

  News Archive

Paving the Way for Metastasis
Tuesday, March 15, 2016
Cancer cells remodel their environment to make it easier to reach nearby blood vessels.

Scientists Synthesize Anti-Cancer Agent
Monday, March 14, 2016
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.

Best Practices for Breast Cancer Diagnosis
Monday, March 14, 2016
Agilent has published “Breast Cancer Diagnosis: Past, Present and Future,” a white paper on the use of immunohistochemistry in diagnosing and treating breast cancer.

Preceyes Enters into Collaborations With NightstaRx and the University of Oxford
Saturday, March 12, 2016
Company has announced collaboration with Nightstar and University of Oxford for the development of a high-precision subretinal drug delivery technology.

PhoreMost and The Wistar Institute Collaborate to Identify New Druggable Targets
Friday, March 11, 2016
Company has announced collaboration with The Wistar Institute to identified and de-orphan novel targets in cancer, aging and the immune system.

Largest Genomic Study on Kidney Cancer Brings Hope for More Effective Treatments
Tuesday, March 08, 2016
Researchers at Baylor College of Medicine have found that a pathway called immune checkpoint was most active in a subtype of clear cell kidney cancer that is typically very aggressive.

Discovery of Likely Subtypes of Rare Childhood Brain Tumor Signals Diagnostic Advance
Saturday, March 05, 2016
Researchers at St. Jude Children’s Research Hospital and German Cancer Research Center have identified that the molecular analysis is likely to improve classification and diagnosis of a rare brain tumor and advance precision medicine.

Rosetta Genomics Receives Approval
Friday, March 04, 2016
Company has announced conditional approval status for RosettaGX Reveal™, its novel microRNA classifier for the diagnosis of indeterminate thyroid fine needle aspirate.

Albumedix Announces Exclusive Commercialization Agreement with ThioLogics
Friday, March 04, 2016
Company has announced agreement with ThioLogics to commercialize the next generation of stable albumin drug conjugates.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 4051

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos